Screener
AnaptysBio, Inc. ANAB Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | March 31, 2026(unaudited) | December 31, 2025 |
|---|---|---|
| Total assets | $329,684 | $364,395 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $7,517 | $3,871 |
| Accrued expenses | 32,065 | 32,674 |
| Current portion of operating lease liability | 2,120 | 2,080 |
| Total current liabilities | 41,702 | 38,625 |
| Liability related to sale of future royalties | 263,742 | 276,528 |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s accounts payable?
- AnaptysBio, Inc. (ANAB) reported accounts payable of $7.52M in Q1 2026.
- How has AnaptysBio, Inc.'s accounts payable changed year-over-year?
- AnaptysBio, Inc.'s accounts payable increased by 22.8% year-over-year, from $6.12M to $7.52M.
- What is the long-term trend for AnaptysBio, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), AnaptysBio, Inc.'s accounts payable has grown at a -1.7% compound annual growth rate (CAGR), from $4.22M to $3.87M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about AnaptysBio, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude